Skip to content
Specimen Atlas of Research Peptides81 plates · MIT
Side-by-side · Research reference

GlutathionevsSemax

Side-by-side comparison across mechanism, dosage, evidence, side effects, administration, and stack synergies. Citations on every claim where available.

AHuman-MechanisticHUMAN-REVIEWED6/39 cited
BHuman-MechanisticAUTO-DRAFTED12/39 cited
Glutathione
Endogenous Tripeptide · Antioxidant
γ-Glu-Cys-GlyStructure
UbiquitousTissue distribution
GCL + GSBiosynthesisWang 2026Aiana 2026
IV · Oral · Inhaled
Semax
Cognitive enhancer · Russian Pharma
200–600 mcg/doseIntranasalKaplan 2017
HumanMechanisticKaplan 2017
~30 minOnset
Intranasal · 2–3×/day during cognitive demand

01Mechanism of Action

Parameter
Glutathione
Semax
Primary target
Intracellular redox systems, glutathione peroxidase, glutathione transferase
BDNF / NGF expression + monoamine modulationKaplan 2017
Pathway
Synthesized via glutamate-cysteine ligase (GCL) → γ-glutamylcysteine → glutathione synthetase (GS) → GSH
↑ BDNF + NGF synthesis + 5-HT modulation → neuroplasticity + anxiolysis + cognitive enhancementKaplan 2017
Downstream effect
Reduction of reactive oxygen species, conjugation of electrophiles, maintenance of cellular thiol-disulfide balance, GPX4 activation for lipid peroxide reduction
Improved memory + attention; reduced anxiety; neuroprotection in ischemiaKaplan 2017
Feedback intact?
Origin
Endogenous tripeptide; predominantly synthesized in liver, exported to extracellular space and tissuesTerrell 2025Hecht 2026
Synthetic 7-AA peptide derived from ACTH(4-7) with C-terminal Pro-Gly-Pro stabilising tailKaplan 2017
Antibody development

02Dosage Protocols

Parameter
Glutathione
Semax
Endogenous synthesis
Hepatic synthesis ~10 g/day (basal rate)
Tissue-specific; demand-driven upregulation via Nrf2 signaling.
Exogenous oral
250–1000 mg/day
Bioavailability limited; gastric hydrolysis reduces systemic uptake.
IV supplementation
600–1200 mg (research protocols)
Used in clinical oxidative stress and hepatic detoxification studies.
Precursor strategy
N-acetylcysteine (NAC) 600–1200 mg/day
Provides cysteine for endogenous GSH synthesis; bypasses GI degradation.
Evidence basis
Animal mechanistic + human mechanistic
Human-mechanistic + Russian clinicalKaplan 2017
Standard dose
200–600 mcg / dose intranasalKaplan 2017
Frequency
2–3× per day during cognitive demand
Lower / starter dose
100 mcg / dose
Duration
10–14 day cycles, repeated PRN
Reconstitution
Pre-formulated nasal spray (commercial); research vial: bacteriostatic water
Timing
Morning + early afternoon
Half-life
Short plasma; CNS effect lasts ~3–6 hr

04Side Effects & Safety

Parameter
Glutathione
Semax
Oral supplementation
GI discomfort, bloating (mild, dose-dependent)
IV administration
Rare hypersensitivity, infusion site reaction
Inhalation
Bronchospasm risk in asthma (rare)
Tumor metabolism
Extracellular GSH catabolism supplies cysteine to tumors; theoretical concern in active malignancyHecht 2026
Nasal irritation
Mild burning or congestion (transient)
Sleep disruption
Late-day dosing may interfere with sleep
Headache
Uncommon, transient
Long-term safety
Limited Western RCT data
Pregnancy / OB
Avoid
Absolute Contraindications
Glutathione
Semax
  • ·Pregnancy / breastfeeding
Relative Contraindications
Glutathione
  • ·Active malignancy (theoretical cysteine supply risk)Hecht 2026
  • ·Severe asthma (inhaled formulations)
Semax
  • ·Active psychiatric instability
  • ·Concurrent strong stimulants

05Administration Protocol

Parameter
Glutathione
Semax
1. Oral administration
Capsule or liquid form, 250–1000 mg once daily. Take on empty stomach for improved absorption, though GI hydrolysis limits bioavailability. NAC precursor strategy often preferred.
Pre-formulated nasal spray (commercial) or research vial reconstituted with bacteriostatic water.
2. Intravenous
Clinical protocols: 600–1200 mg slow infusion over 30–60 minutes. Used for acute oxidative stress, hepatic detoxification support. Administered in medical settings.
Intranasal — 2–3 sprays per nostril per dose. Tilt head slightly back.
3. Inhaled formulations
Nebulized GSH (research protocols). Monitor for bronchospasm in reactive airway patients. Used experimentally for pulmonary oxidative stress.
Morning + early afternoon. Avoid evening (sleep disruption).
4. Precursor supplementation
N-acetylcysteine (NAC) 600–1200 mg/day PO. Provides cysteine substrate for endogenous GSH synthesis. Bypasses gastric degradation, preferred for chronic supplementation.
Refrigerate after reconstitution; light-protected.
5. Caveat
Cycle on/off to avoid neurochemical adaptation.

06Stack Synergy

Glutathione
— no documented stacks
Semax
+ Selank
Moderate
View Selank

Semax (cognitive enhancer, BDNF/NGF) and Selank (anxiolytic + immune) form the canonical Russian "neuro stack" — both intranasal peptide bioregulators with complementary axes. Semax for cognitive demand; Selank for stress mitigation.

Semax
200–600 mcg intranasal · morning + afternoon
Selank
150–300 mcg intranasal · midday + early evening
Primary benefit
Cognitive enhancement + stress mitigation